251 related articles for article (PubMed ID: 30235871)
1. Deep Brain Stimulation Modified Autism-Like Deficits via the Serotonin System in a Valproic Acid-Induced Rat Model.
Wu HF; Chen YJ; Chu MC; Hsu YT; Lu TY; Chen IT; Chen PS; Lin HC
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235871
[TBL] [Abstract][Full Text] [Related]
2. 5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model.
Wang CC; Lin HC; Chan YH; Gean PW; Yang YK; Chen PS
Int J Neuropsychopharmacol; 2013 Oct; 16(9):2027-39. PubMed ID: 23823694
[TBL] [Abstract][Full Text] [Related]
3.
Wu HF; Chen PS; Hsu YT; Lee CW; Wang TF; Chen YJ; Lin HC
Mol Neurobiol; 2018 Jun; 55(6):4811-4824. PubMed ID: 28733898
[TBL] [Abstract][Full Text] [Related]
4. Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic system.
Volle J; Bregman T; Scott B; Diwan M; Raymond R; Fletcher PJ; Nobrega JN; Hamani C
Neuropharmacology; 2018 Jun; 135():63-72. PubMed ID: 29505786
[TBL] [Abstract][Full Text] [Related]
5. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism.
Kim JW; Seung H; Kim KC; Gonzales ELT; Oh HA; Yang SM; Ko MJ; Han SH; Banerjee S; Shin CY
Neuropharmacology; 2017 Feb; 113(Pt A):71-81. PubMed ID: 27638451
[TBL] [Abstract][Full Text] [Related]
6. 5-HT7 receptor activation rescues impaired synaptic plasticity in an autistic-like rat model induced by prenatal VPA exposure.
Khodaverdi M; Rahdar M; Davoudi S; Hajisoltani R; Tavassoli Z; Ghasemi Z; Amini AE; Hosseinmardi N; Behzadi G; Janahmadi M
Neurobiol Learn Mem; 2021 Sep; 183():107462. PubMed ID: 34015444
[TBL] [Abstract][Full Text] [Related]
7. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
Gogos A; Kwek P; Chavez C; van den Buuse M
J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
[TBL] [Abstract][Full Text] [Related]
8. The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors.
Calcagno E; Carli M; Invernizzi RW
J Neurochem; 2006 Feb; 96(3):853-60. PubMed ID: 16405507
[TBL] [Abstract][Full Text] [Related]
9. Serotonin modifies the spontaneous spiking activity of gracile nucleus neurons in rats: role of 5-HT1A and 5-HT2 receptors.
Grasso C; Li Volsi G; Barresi M
Arch Ital Biol; 2016 Jun; 154(2-3):39-49. PubMed ID: 27918061
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
Zhang Z; Rickard JF; Body S; Asgari K; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2005 Sep; 181(2):381-91. PubMed ID: 15830225
[TBL] [Abstract][Full Text] [Related]
11. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
12. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
[TBL] [Abstract][Full Text] [Related]
13. MR imaging central thalamic deep brain stimulation restored autistic-like social deficits in the rat.
Lin TC; Lo YC; Lin HC; Li SJ; Lin SH; Wu HF; Chu MC; Lee CW; Lin IC; Chang CW; Liu YC; Chen TC; Lin YJ; Ian Shih YY; Chen YY
Brain Stimul; 2019; 12(6):1410-1420. PubMed ID: 31324604
[TBL] [Abstract][Full Text] [Related]
14. Sociability deficits after prenatal exposure to valproic acid are rescued by early social enrichment.
Campolongo M; Kazlauskas N; Falasco G; Urrutia L; Salgueiro N; Höcht C; Depino AM
Mol Autism; 2018; 9():36. PubMed ID: 29946415
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
16. Alleviation of N-Methyl-D-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3β Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism.
Wu HF; Chen PS; Chen YJ; Lee CW; Chen IT; Lin HC
Mol Neurobiol; 2017 Sep; 54(7):5264-5276. PubMed ID: 27578017
[TBL] [Abstract][Full Text] [Related]
17. 5-hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures.
Madhavan L; Freed WJ; Anantharam V; Kanthasamy AG
J Pharmacol Exp Ther; 2003 Mar; 304(3):913-23. PubMed ID: 12604665
[TBL] [Abstract][Full Text] [Related]
18. Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function.
Mohammadi S; Asadi-Shekaari M; Basiri M; Parvan M; Shabani M; Nozari M
Psychopharmacology (Berl); 2020 Jan; 237(1):199-208. PubMed ID: 31595334
[TBL] [Abstract][Full Text] [Related]
19. Extending therapeutic use of psychostimulants: focus on serotonin-1A receptor.
Haleem DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():170-80. PubMed ID: 23906987
[TBL] [Abstract][Full Text] [Related]
20. Continuous high-frequency deep brain stimulation of the anterior insula modulates autism-like behavior in a valproic acid-induced rat model.
Xiao L; Jiang S; Wang Y; Gao C; Liu C; Huo X; Li W; Guo B; Wang C; Sun Y; Wang A; Feng Y; Wang F; Sun T
J Transl Med; 2022 Dec; 20(1):570. PubMed ID: 36474209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
